Stockwatch: Runners And Riders In The Coronavirus Stakes
Generalist Investors Among Possible Losers In The Pandemic
With so many companies developing treatments and vaccines against coronavirus, and most other affected by the pandemic, they can’t all be winners.
You may also be interested in...
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
An official announcement is expected within weeks, as competition between US and China stokes fears of 'vaccine nationalism'.
After a slow start marked by product withdrawals and toxicity, recent deal-making activity has brought antibody-drug conjugates back from obscurity. But what has changed?